Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

Clinical trial NCT04804813 · COMPLETED

Trial details

NCT number: NCT04804813
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma

Start date: 2021-03-29
Primary completion: 2024-07-25
Enrollment: 388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.